PUBLISHER: GlobalData | PRODUCT CODE: 1410766
PUBLISHER: GlobalData | PRODUCT CODE: 1410766
Bone Densitometers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.
The model discusses in detail the impact of COVID-19 on Bone Densitometers market for the year 2020 and beyond. Bone Densitometers harness X-rays to examine and quantify a patient's bone density. Bone density tests are used to assess fracture risk, investigate height loss, diagnose and monitor osteoporosis, and monitor steroid treatment (or other drugs that may affect bone density such as anti-organ rejection medication). DXA machines are the gold-standard for bone densitometry. ADEXA machines are an important tool for assessing fracture risk in fragile areas of the body in osteoporosis patients, such as the hip and spine.
Although they are more expensive, they are more equipped to handle these areas of the body. PDEXA machines, which are smaller, less expensive and portable are less sought after, though they are far more useful the peripheral anatomies such as hands and ankles. QUS machines are also less commonly used, although they are very useful for monitoring regular patients.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Bone Densitometers and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: GE Healthcare Technologies Inc, Hologic Inc, Diagnostic Medical Systems SA, Swissray Medical AG, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable